Skip to content
10-Q

Quarterly Report

Tango Therapeutics, Inc. TNGX

0001193125-25-263680

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 28, 2025 134.59M sh
Shares Diluted Q3 2025 · Sep 30, 2025 117.78M sh
Shares Diluted Q3 2025 · Sep 30, 2025 110.76M sh
Shares Diluted Q3 2025 · Sep 30, 2024 108.51M sh
Shares Diluted Q3 2025 · Sep 30, 2024 108.99M sh
Capex Q3 2025 · Sep 30, 2025 $826K
Capex Q3 2025 · Sep 30, 2024 $630K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$109.17M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$94.85M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $58.34M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $69.53M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $53.15M
Stockholders Equity Q3 2025 · Sep 30, 2025 $160.03M
Stockholders Equity Q3 2025 · Jun 30, 2025 $134.95M
Stockholders Equity Q3 2025 · Mar 31, 2025 $166.76M
Stockholders Equity Q3 2025 · Dec 31, 2024 $199.52M
Stockholders Equity Q3 2025 · Sep 30, 2024 $229.17M
Stockholders Equity Q3 2025 · Jun 30, 2024 $247.67M
Stockholders Equity Q3 2025 · Mar 31, 2024 $264.45M
Stockholders Equity Q3 2025 · Dec 31, 2023 $253.11M
Current Liabilities Q3 2025 · Sep 30, 2025 $18.44M
Current Liabilities Q3 2025 · Dec 31, 2024 $38.17M
Total Liabilities Q3 2025 · Sep 30, 2025 $50.11M
Total Liabilities Q3 2025 · Dec 31, 2024 $116.98M
Current Assets Q3 2025 · Sep 30, 2025 $163.78M
Current Assets Q3 2025 · Dec 31, 2024 $266.34M
Total Assets Q3 2025 · Sep 30, 2025 $210.14M
Total Assets Q3 2025 · Dec 31, 2024 $316.49M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.57
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.27
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.85
Eps Basic Q3 2025 · Sep 30, 2025 $0.14
Eps Basic Q3 2025 · Sep 30, 2025 −$0.57
Eps Basic Q3 2025 · Sep 30, 2024 −$0.27
Eps Basic Q3 2025 · Sep 30, 2024 −$0.85
Sga Expense Q3 2025 · Sep 30, 2025 $8.92M
Sga Expense Q3 2025 · Sep 30, 2025 $31.75M
Sga Expense Q3 2025 · Sep 30, 2024 $11.22M
Sga Expense Q3 2025 · Sep 30, 2024 $32.66M
Rd Expense Q3 2025 · Sep 30, 2025 $30.82M
Rd Expense Q3 2025 · Sep 30, 2025 $100.06M
Rd Expense Q3 2025 · Sep 30, 2024 $33.26M
Rd Expense Q3 2025 · Sep 30, 2024 $109.98M
Net Income Q3 2025 · Sep 30, 2025 $15.88M
Net Income Q3 2025 · Sep 30, 2025 −$62.85M
Net Income Q3 2025 · Jun 30, 2025 −$38.85M
Net Income Q3 2025 · Mar 31, 2025 −$39.88M
Net Income Q3 2025 · Sep 30, 2024 −$29.17M
Net Income Q3 2025 · Sep 30, 2024 −$92.63M
Net Income Q3 2025 · Jun 30, 2024 −$25.55M
Net Income Q3 2025 · Mar 31, 2024 −$37.91M
Operating Income Q3 2025 · Sep 30, 2025 $14.07M
Operating Income Q3 2025 · Sep 30, 2025 −$69.43M
Operating Income Q3 2025 · Sep 30, 2024 −$32.88M
Operating Income Q3 2025 · Sep 30, 2024 −$104.69M
Revenue Q3 2025 · Sep 30, 2025 $53.81M
Revenue Q3 2025 · Sep 30, 2025 $62.38M
Revenue Q3 2025 · Sep 30, 2024 $11.61M
Revenue Q3 2025 · Sep 30, 2024 $37.95M